How this report will benefit you: <\/p>
Read on to discover how you can exploit the future business opportunities emerging in this sector. <\/p>
In this brand-new127 page reportyou will receive70 charts- all unavailable elsewhere. <\/p>
The127-page report provides clear detailed insight into the gene therapy market. Discover the key drivers and challenges affecting the market. <\/p>
By ordering and reading our brand-new report today you stay better informed and ready to act. <\/p>
Report Scope: <\/p>
Gene Therapy market forecastsfrom2017-2027 <\/p>
This reportassesses the approved gene therapy productsin the market and givesrevenue to 2027 for Neovasculgen <\/p>
Providesqualitative analysis and forecastof thesubmarket by indicationfor the period 2017-2027: Cancer Cardiovascular disorders Rare diseases Ophthalmological diseases Other therapeutic uses <\/p>
Profilesleading companiesthat will be important in the development of the gene therapy market. For each company, developments and outlooks are discussed and companies covered in this chapter include: UniQure Biogen Bluebird Bio Spark Therapeutics Applied Genetics Technologies Corporation Oxford Biomedica GenSight Biologics <\/p>
Assesses the outlook for theleading gene treatment R&D pipelinefor 2016 and discusses technological progress and potential. Profiles appear for gene therapy drug candidates, withrevenue forecasts for six leading agents: SPK-RPE65 (Spark Therapeutics) Collategene (AMG0001, AnGes MG\/Vical) Invossa (TissueGene-C, TissueGene Inc\/Kolon Life Science) BC-819 (BioCancell) Lenti-D (Bluebird Bio) GSK2696273 (GlaxoSmithKline) <\/p>
Provides qualitative analysis of trends that will affect the gene therapies market, from the perspective of pharmaceutical companies, during the period 2017 to 2027.SWOT analysisis provided andan overview of regulation of the gene therapy market by leading regiongiven. <\/p>
Our study discussesfactors that influence the marketincluding these: Translation of research into marketable products modifying human DNA - gene transfer for therapeutic use, altering the nuclear genome Genomic editing technology and other supporting components Collaborations to develop and launch gene-based products - acquisitions and licensing deals Supporting technologies for human genetic modification, gene replacement and targeted drug delivery Gene therapies for ophthalmologic diseases - next-generation medicines Regulations in the United States, the European Union and Japan - overcoming technological and medical challenges to pass clinical trials. <\/p>
Visiongain's study is intended for anyone requiring commercial analyses for the gene therapy market. You find data, trends and predictions. <\/p>
Buy our report todayGene Therapy R&D and Revenue Forecasts 2017-2027: Cancer, Cardiovascular, Rare Diseases, Ophthalmologic, Other Diseases. <\/p>
To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com<\/a> or call Tel: +44-(0)-20-7336-6100 <\/p> Or click on https:\/\/www.visiongain.com\/Report\/1954\/Gene-Therapy-R-D-and-Revenue-Forecasts-2017-2027<\/a> <\/p> List of Companies and Organisations Mentioned in the Report: <\/p> Active Medical, Inc. <\/p> AngioDynamics, Inc. <\/p> Aspen Laboratories <\/p> AtriCure, Inc. <\/p> Barcapel Foundation <\/p> Biosense Webster, Inc. <\/p> Boston Scientific Corporation <\/p> British Association of Aesthetic Plastic Surgeons (BAAPS) <\/p> BSD Medical Corporation <\/p> C.R. Bard <\/p> Cosman medical, Inc. <\/p> Covidien <\/p> DFINE, Inc. <\/p> Endosense SA <\/p> Ethicon <\/p> Food and Drug Administration (FDA) <\/p> Galil medical, Inc. <\/p> Johnson & Johnson <\/p> Linvatec Canada ULC <\/p> Macmillan Cancer Support <\/p> Medtronic <\/p> Microsulis Medical Ltd. <\/p> Monteris Medical <\/p> National Institute of Health Research (NIHR) <\/p> nContact, Inc. <\/p> NeuroTherm, Inc. <\/p> NeuWave Medical, Inc. <\/p> NxThera, Inc. <\/p> Olympus Corporation <\/p> Perseon Corporation <\/p> Profound Medical Corp. <\/p> Royal Brompton & Harefield NHS Foundation Trust <\/p> Royal Philips <\/p> Shandong Provincial Hospital <\/p> Smith & Nephew <\/p> SonaCare Medical <\/p> St Jude Medical <\/p> Terumo Europe <\/p> The American Heart Association <\/p> Trod Medical N.V. <\/p> University College London <\/p> To see a report overview please email Sara Peerun on sara.peerun@visiongain.com<\/a> <\/p> SOURCE Visiongain Ltd <\/p> <\/p> See the rest here: <\/p> Gene Therapy R&D and Revenue Forecasts 2017-2027 - PR Newswire (press release)<\/a><\/p>","protected":false},"excerpt":{"rendered":" (Logo: http:\/\/mma.prnewswire.com\/media\/523989\/Visiongain_Logo.jpg<\/a> ) How this report will benefit you: Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand-new127 page reportyou will receive70 charts- all unavailable elsewhere. Continue reading ![](\"http:\/\/mma.prnewswire.com\/media\/523989\/Visiongain_Logo.jpg\"){kind=logo}
<\/p>